Press Room

CPHI China 2024

Start
Wednesday, June 19, 2024
End
Friday, June 21, 2024
Location: Shanghai, China
Booth Number: E2B72

Visit Hovione’s booth at CPHI China - Booth No. E2B72 

CPHI China is a renowned meeting place for suppliers and buyers from the entire pharmaceutical supply chain, bringing leading pharma professionals together to network, learn and conduct vital face-to-face business. 

We look forward to seeing you at CPHI China.  

As a fully integrated CDMO we provide optimal solutions for your drug product with the right scale and flexibility.  

Meet our team and learn more about Hovione’s latest technologies and innovations in drug development and how we can support your project. 

schedule a meeting

 

 

 

 

 

Schedule your meeting today and find out how we can support your project. 

 

The Leader in Spray Drying 

Learn more on how to overcome your solubility issues with the best scale-up science. 

 

Inhalation and Nasal  

Know more about our complete One-Site Solution that ensures that your inhalation and nasal therapies are engineered for success from start to finish. 

 

 

 

Find more about CPHI China

 

 

Also in the Press Room

See All

Lisbon, Portugal – Hovione, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, Hovione joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At Hovione, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of Hovione. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” Hovione will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with Hovione’s sustainability ambitions.  Hovione remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024